Massachusetts residents are sick and tired of paying taxes, and a new poll shows strong opposition from likely voters on Gov.

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

After days of Democratic agonizing, the Senate voted to keep federal funds flowing through Sept. 30 just hours before a ...

The measure, which passed with bipartisan support and minor changes, now heads back to the House. It is just the second ...

The Senate is preparing to give final approval to a bill that could result in harsher prison sentences for fentanyl ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

But what if you could avoid getting COVID-19 altogether? That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific conference in San ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

The study, published March 12 in JAMA Network Open, compared the newly approved tenecteplase in a single quick injection to alteplase, the stroke treatment that has been used for decades and requires ...